IP Library Granted Patent US 9,265,865
Granted Patent B2
US 9,265,865 · App. 11/428,014 · Granted Feb 23, 2016

Stent having time-release indicator

Inventors: Jessica Hixon (Watertown, MA); Bryan Kostelac (Camby, IN)
Assignee: Boston Scientific Scimed, Inc.
A61L31/148A61F2/04A61L31/16A61M27/008A61F13/34A61F13/42A61F2002/048A61F2002/9528A61F2013/422A61F2250/0029A61F2250/0031A61F2250/0035A61F2250/0079A61L15/56A61L2300/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,265,865
App. No.
11/428,014
Granted
Feb 23, 2016
Kind
B2
Abstract

A medical device includes an elongate body configured to be disposed within a urinary tract of a patient such that a first end portion of the elongate body is disposed at a first location of the urinary tract and a second end portion of the elongate body is disposed at a second, different location of the urinary tract. The elongate body defines a lumen that is configured to convey urine from the first location of the urinary tract to the second location of the urinary tract. An agent is formulated to visually alter urine of the patient, the agent is coupled to the elongate body and releasable into the patient's urine.

Claims (9)

1. A medical device, comprising:

a ureteral stent including an elongate body, the elongate body being configured to be disposed within a urinary tract of a patient such that a first curved retention member of the elongate body is disposed in a kidney of the patient to help retain the medical device in place within the urinary tract and a second curved retention member of the elongate body is disposed in a bladder of the patient to help retain the medical device in place within the urinary tract, the elongate body defining a lumen, the lumen being configured to convey urine from the kidney to the bladder;

a release element including a base member and a barrier member, the barrier member disposed around the base member, the barrier member formed with a biodegradable material, the barrier member and the base member collectively defining a reservoir therebetween;

a liquid agent disposed within the reservoir, the agent formulated to visually alter urine of the patient upon degradation of the barrier member by contact with the patient's urinary tract or urine therein; and

a tether having a first end portion coupled to the second curved retention member of the elongate body and a second end portion coupled to the release element, the tether being configured to allow the release element to move with respect to the elongate body.

2. The medical device of claim 1 , wherein the liquid agent is formulated to visually alter a color of a patient's urine.

3. The medical device of claim 1 , wherein the reservoir is annularly disposed between the base member and the barrier member.

4. The medical device of claim 1 , wherein the release element is configured to be entirely disposed within a bladder of the patient when at least a portion of the elongate body is disposed in a ureter of the patient.

5. The medical device of claim 1 , wherein the tether is configured to allow the release element to move with respect to the elongate body such that a longitudinal axis defined by the release element is non-parallel to a longitudinal axis defined by the elongate body.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2006
From: HIXON, JESSICA; KOSTELAC, BRYAN
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 017874/0864 →
Continuity (1)
Related Publication 20080004578A1 · Jan 3, 2008